Peter Moldt Intends to Resign from the Board as Well as Each of the Audit Committee and Nominating and Corporate Governance Committee of Corvus Pharmaceuticals, Inc

On December 12, 2018, Corvus Pharmaceuticals, Inc. announced that Peter Moldt Ph.D. notified the Company of his intention to resign from the Board as well as each of the audit committee and nominating and corporate governance committee in the first half of 2019.